Motif Bio PLC Conversion of CPNs, PDMR Dealing & TVR (5423S)
December 21 2016 - 11:50AM
UK Regulatory
TIDMMTFB
RNS Number : 5423S
Motif Bio PLC
21 December 2016
This announcement contains inside information
Motif Bio plc
("Motif Bio" or the "Company")
Conversion of Convertible Promissory Notes, PDMR Dealing and
Total Voting Rights
Motif Bio plc (AIM: MTFB) the clinical stage biopharmaceutical
company specialising in developing novel antibiotics announces,
that it has issued, in aggregate, 14,510,770 new ordinary shares in
the Company ("Ordinary Shares") following the conversion by Amphion
Innovations plc and Amphion Innovations US Inc., (the "Amphion
Parties") of the Convertible Promissory Notes ("CPNs"). The CPNs
which totalled US$3,550,786 were converted in accordance with their
terms at US$0.2447 per share.
Following the conversion, the Amphion Parties will hold no
further CPNs and their holding will total 43,240,645 ordinary
shares being 22 per cent. of the Company.
Richard Morgan and Robert Bertoldi, Non-Executive Chairman and
Executive Director of the Company respectively, are also directors
of Amphion Innovations plc (the "Amphion Directors"). Amphion
Innovations plc is therefore a "Person Closely Associated" with the
Amphion Directors under the Market Abuse Regulation.
Application has been made for the 14,510,770 new Ordinary Shares
to be admitted to trading on AIM ("Admission"), which is expected
to occur at 8.00 a.m. on 29 December 2016. The new Ordinary Shares
will rank pari passu with the existing Ordinary Shares. Following
Admission, and for the purposes of the Disclosure and Transparency
Rules, the Company's total issued share capital will consist of
195,741,528 Ordinary Shares. Shareholders may use this figure as
the denominator for the calculations by which they will determine
if they are required to notify their interest in, or a change to
their interest in, the issued share capital of the Company.
For further information, please contact:
Motif Bio plc info@motifbio.com
Graham Lumsden (Chief
Executive Officer)
Zeus Capital Limited
(NOMAD & BROKER) +44 (0)20 3829 5000
Phil Walker/Giles Balleny
Dominic Wilson
Northland Capital Partners
Limited (BROKER) +44 (0)203 861 6625
Patrick Claridge/ David
Hignell
John Howes/ Rob Rees
(Broking)
Walbrook PR Ltd. (FINANCIAL +44 (0) 20 7933 8780 or
PR & IR) motifbio@walbrookpr.com
Paul McManus Mob: +44 (0)7980 541
893
Mike Wort Mob: +44 (0)7900 608
002
MC Services AG (EUROPEAN
IR) +49 (0)89 210 2280
Raimund Gabriel
This information is provided by RNS
The company news service from the London Stock Exchange
1 Details of the person discharging managerial responsibilities/person closely associated
------ -----------------------------------------------------------------------------------------------
a) Name Amphion Innovations Plc
------ -------------------------------------------- -------------------------------------------------
2 Reason for the notification
------ -----------------------------------------------------------------------------------------------
Person Closely Associated with
a) Position/status PDMRs of Motif Bio Plc (Robert
Bertoldi and Richard Morgan)
------ -------------------------------------------- -------------------------------------------------
b) Initial notification/Amendment Initial Notification
------ -------------------------------------------- -------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
------ -----------------------------------------------------------------------------------------------
a) Name Motif Bio Plc
------ -------------------------------------------- -------------------------------------------------
b) LEI N/A
------ -------------------------------------------- -------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
------ -----------------------------------------------------------------------------------------------
a) Description of the Ordinary Shares
financial instrument,
type of instrument ISIN GB00BVVT4H71
Identification code
------ -------------------------------------------- -------------------------------------------------
b) Nature of the transaction Exercise of Convertible Promissory
Notes into 14,510,770 Ordinary
Shares
------ -------------------------------------------- -------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- -----------
N/A 14,510,770
---------- -----------
------ -------------------------------------------- -------------------------------------------------
d) Aggregated information Price(s) Volume(s)
---------- -----------
N/A 14,510,770
---------- -----------
------ -------------------------------------------- -------------------------------------------------
e) Date of the transaction 21December 2016
------ -------------------------------------------- -------------------------------------------------
f) Place of the transaction N/A
------ -------------------------------------------- -------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUASBRNWAUUAA
(END) Dow Jones Newswires
December 21, 2016 12:50 ET (17:50 GMT)
Motif Bio (LSE:MTFB)
Historical Stock Chart
From May 2024 to Jun 2024
Motif Bio (LSE:MTFB)
Historical Stock Chart
From Jun 2023 to Jun 2024